Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avi Kumar Bansal

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos Medicine|December 10, 2021
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional studyManoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Epidemiology and Infection|November 18, 2024
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in IndiaChristine Prosperi, Alvira Z Hasan, Amy K Winter, et al.
Plos One|March 29, 2024
Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020Jeromie Wesley Vivian Thangaraj, Christine Prosperi, Muthusamy Santhosh Kumar, et al.
Journal of Infection and Public Health|November 10, 2023
Prevalence and factors associated with tuberculosis infection in IndiaSriram Selvaraju, Banurekha Velayutham, Raghuram Rao, et al.
The Lancet. Global Health|October 14, 2022
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020Manoj V Murhekar, Nivedita Gupta, Alvira Z Hasan, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Indian Journal of Medical Research|September 21, 2020
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021Manoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos Medicine|December 10, 2021
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional studyManoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Epidemiology and Infection|November 18, 2024
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in IndiaChristine Prosperi, Alvira Z Hasan, Amy K Winter, et al.
Plos One|March 29, 2024
Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020Jeromie Wesley Vivian Thangaraj, Christine Prosperi, Muthusamy Santhosh Kumar, et al.
Journal of Infection and Public Health|November 10, 2023
Prevalence and factors associated with tuberculosis infection in IndiaSriram Selvaraju, Banurekha Velayutham, Raghuram Rao, et al.
The Lancet. Global Health|October 14, 2022
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020Manoj V Murhekar, Nivedita Gupta, Alvira Z Hasan, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Indian Journal of Medical Research|September 21, 2020
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021Manoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Pageof 3